drugset / Trial / NCT00593242

Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy

NCT00593242 ↗

Phase 1 Completed 52 enrolled Michael Cotten
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a pilot study to test feasibility of collection, preparation and infusion of a baby's own (autologous)umbilical cord blood in the first 14 days after birth if the baby is born with signs of brain injury.

Timeline

Start
2008-01
Primary completion
2017-01
Completion
2017-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous cord blood cells Cell therapy 5e+07 cells/kg —

Indications